Abiomed EV/EBIT
Cos'è EV/EBIT di Abiomed?
EV/EBIT di Abiomed Inc. è 47.95
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NASDAQ rispetto a Abiomed
Cosa fa Abiomed?
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Aziende con ev/ebit simili a Abiomed
- Mahindra Holidays & Resorts India ha EV/EBIT di 47.80
- Safari Industries (India) ha EV/EBIT di 47.80
- AdvanSix Inc ha EV/EBIT di 47.85
- Syngene International ha EV/EBIT di 47.87
- Voltas ha EV/EBIT di 47.88
- LXP Industrial Trust ha EV/EBIT di 47.94
- Abiomed ha EV/EBIT di 47.95
- Amadeus IT SA ha EV/EBIT di 47.99
- MSCI ha EV/EBIT di 48.15
- American Finance Trust ha EV/EBIT di 48.16
- American Finance Trust ha EV/EBIT di 48.16
- American Finance Trust ha EV/EBIT di 48.16
- American Finance Trust ha EV/EBIT di 48.16